84 related articles for article (PubMed ID: 15081439)
1. Final results of the ReoPro readministration registry.
Dery JP; Braden GA; Lincoff AM; Kereiakes DJ; Browne K; Little T; George BS; Sane DC; Cines DB; Effron MB; Mascelli MA; Langrall MA; Damaraju L; Barnathan ES; Tcheng JE;
Am J Cardiol; 2004 Apr; 93(8):979-84. PubMed ID: 15081439
[TBL] [Abstract][Full Text] [Related]
2. Abciximab readministration: results of the ReoPro Readministration Registry.
Tcheng JE; Kereiakes DJ; Lincoff AM; George BS; Kleiman NS; Sane DC; Cines DB; Jordan RE; Mascelli MA; Langrall MA; Damaraju L; Schantz A; Effron MB; Braden GA
Circulation; 2001 Aug; 104(8):870-5. PubMed ID: 11514371
[TBL] [Abstract][Full Text] [Related]
3. Readministration of abciximab: interim report of the ReoPro readministration registry.
Tcheng JE; Kereiakes DJ; Braden GA; Jordan RE; Mascelli MA; Langrall MA; Effron MB
Am Heart J; 1999 Jul; 138(1 Pt 2):S33-8. PubMed ID: 10385789
[TBL] [Abstract][Full Text] [Related]
4. Abciximab readministration.
Orford JL; Holmes DR
Rev Cardiovasc Med; 2002; 3(2):67-70. PubMed ID: 12447149
[TBL] [Abstract][Full Text] [Related]
5. Clinical correlates and course of thrombocytopenia during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockade.
Kereiakes DJ; Berkowitz SD; Lincoff AM; Tcheng JE; Wolski K; Achenbach R; Melsheimer R; Anderson K; Califf RM; Topol EJ
Am Heart J; 2000 Jul; 140(1):74-80. PubMed ID: 10874266
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of abciximab readministration in coronary intervention.
Madan M; Kereiakes DJ; Hermiller JB; Rund MM; Tudor G; Anderson L; McDonald MB; Berkowitz SD; Sketch MH; Phillips HR; Tcheng JE
Am J Cardiol; 2000 Feb; 85(4):435-40. PubMed ID: 10728946
[TBL] [Abstract][Full Text] [Related]
7. Bleeding events with abciximab in acute coronary syndromes without early revascularization: An analysis of GUSTO IV-ACS.
Lenderink T; Boersma E; Ruzyllo W; Widimsky P; Ohman EM; Armstrong PW; Wallentin L; Simoons ML;
Am Heart J; 2004 May; 147(5):865-73. PubMed ID: 15131544
[TBL] [Abstract][Full Text] [Related]
8. Severe delayed thrombocytopenia associated with abciximab (ReoPro) therapy.
Reddy MS; Carmody TJ; Kereiakes DJ
Catheter Cardiovasc Interv; 2001 Apr; 52(4):486-8. PubMed ID: 11285605
[TBL] [Abstract][Full Text] [Related]
9. Readministration of abciximab in percutaneous coronary intervention.
Fry ET
J Invasive Cardiol; 1999 Apr; 11(4):251-8. PubMed ID: 10745525
[TBL] [Abstract][Full Text] [Related]
10. Bleeding risks with abciximab after full-dose thrombolysis in rescue or urgent angioplasty for acute myocardial infarction.
Jong P; Cohen EA; Batchelor W; Lazzam C; Kreatsoulas C; Natarajan MK; Strauss BH
Am Heart J; 2001 Feb; 141(2):218-25. PubMed ID: 11174335
[TBL] [Abstract][Full Text] [Related]
11. Predictors of bleeding complications and thrombocytopenia with the use of abciximab during percutaneous coronary intervention.
Razakjr OA; Tan HC; Yip WL; Lim YT
J Interv Cardiol; 2005 Feb; 18(1):33-7. PubMed ID: 15788052
[TBL] [Abstract][Full Text] [Related]
12. Long term efficacy of abciximab bolus-only compared to abciximab bolus and infusion after transradial coronary stenting.
Bagur R; Bertrand OF; Rodés-Cabau J; Larose E; Rinfret S; Nguyen CM; Noel B; Larochellière RD; Poirier P; Costerousse O; Roy L
Catheter Cardiovasc Interv; 2009 Dec; 74(7):1010-6. PubMed ID: 19753635
[TBL] [Abstract][Full Text] [Related]
13. Acute profound thrombocytopenia without bleeding complications after re-administration of abciximab.
Nguyen N; Salib H; Mascarenhas DA
J Invasive Cardiol; 2001 Jan; 13(1):56-8. PubMed ID: 11146690
[TBL] [Abstract][Full Text] [Related]
14. Abciximab readministration: A single-operator community-hospital experience.
Arjomand H; Magsi ZM; Chang KS; Mascarenhas DA
Catheter Cardiovasc Interv; 1999 Jul; 47(3):294-6; discussion 297. PubMed ID: 10402280
[TBL] [Abstract][Full Text] [Related]
15. Thrombocytopenia caused by abciximab or tirofiban and its association with clinical outcome in patients undergoing coronary stenting.
Merlini PA; Rossi M; Menozzi A; Buratti S; Brennan DM; Moliterno DJ; Topol EJ; Ardissino D
Circulation; 2004 May; 109(18):2203-6. PubMed ID: 15117843
[TBL] [Abstract][Full Text] [Related]
16. Clinical efficacy and safety of intracoronary vs. intravenous abciximab administration in STEMI patients undergoing primary percutaneous coronary intervention: a meta-analysis of randomized trials.
Navarese EP; Kozinski M; Obonska K; Margheri M; Gurbel PA; Kubica J; De Luca G
Platelets; 2012; 23(4):274-81. PubMed ID: 21988317
[TBL] [Abstract][Full Text] [Related]
17. European registry on patients with ST-elevation myocardial infarction transferred for mechanical reperfusion with a special focus on early administration of abciximab -- EUROTRANSFER Registry.
Dudek D; Siudak Z; Janzon M; Birkemeyer R; Aldama-Lopez G; Lettieri C; Janus B; Wisniewski A; Berti S; Olivari Z; Rakowski T; Partyka L; Goedicke J; Zmudka K;
Am Heart J; 2008 Dec; 156(6):1147-54. PubMed ID: 19033011
[TBL] [Abstract][Full Text] [Related]
18. Benefit of bolus-only platelet glycoprotein IIb/IIIa inhibition during percutaneous coronary intervention: insights from the very early outcomes in the Evaluation of 7E3 for the Prevention of Ischemic Complications (EPIC) trial.
Marmur JD; Mitre CA; Barnathan E; Cavusoglu E
Am Heart J; 2006 Nov; 152(5):876-81. PubMed ID: 17070148
[TBL] [Abstract][Full Text] [Related]
19. Abciximab, ticlopidine, and concomitant abciximab-ticlopidine therapy: ex vivo platelet aggregation inhibition profiles in patients undergoing percutaneous coronary interventions.
Kleiman NS; Grazeiadei N; Maresh K; Taylor RJ; Frederick B; Lance ET; Effron MB; Jordan RE; Mascelli MA
Am Heart J; 2000 Sep; 140(3):492-501. PubMed ID: 10966553
[TBL] [Abstract][Full Text] [Related]
20. Glycoprotein IIb/IIIa receptor inhibition with abciximab during percutaneous coronary interventions increases the risk of bleeding in patients with impaired renal function.
Pinkau T; Ndrepepa G; Kastrati A; Mann JF; Schulz S; Mehilli J; Schömig A
Cardiology; 2008; 111(4):247-53. PubMed ID: 18434733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
